American Society of Clinical Oncology

SHERPA: White

People

  1. Bosl
    Bosl
  2. Feldman
    Feldman
  3. Bajorin
    Bajorin
  4. Motzer
    Motzer
  5. Reuter
    Reuter
  6. Sheinfeld
    Sheinfeld
  7. Funt
    Funt
  8. Al-Ahmadie
    Al-Ahmadie
  9. McHugh
    McHugh
  10. Solit
    Solit

Groups

  1. Department of Medicine (22)
  2. Genitourinary Oncology Service (22)
  3. Solid Tumor Oncology Division (22)
  4. Survivorship Research (22)
  5. Surgery (15)
  6. Urology (15)
  7. Biostatistics Service (14)
  8. Epidemiology and Biostatistics (14)
  9. GSK Faculty (6)
  10. Human Oncology and Pathogenesis Program (6)
Search Within
  1. "George Bosl"
  2. "Victor Reuter"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (9)
Groups
  1. Department of Medicine (22)
  2. Genitourinary Oncology Service (22)
  3. Solid Tumor Oncology Division (22)
  4. Survivorship Research (22)
  5. Surgery (15)
  6. Urology (15)

More Groups

People
  1. George Bosl (22)
  2. Victor Reuter (22)
  3. Darren Feldman (18)
  4. Dean Bajorin (17)
  5. Robert Motzer (16)
  6. Joel Sheinfeld (15)

More People

Years
  1. 2020 (2)
  2. 2019 (4)
  3. 2018 (4)
  4. 2017 (2)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. JCO Precision Oncology (1)

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germ cell tumor molecular heterogeneity revealed through analysis of primary and metastasis pairs
    Journal Article

    Cheng, M. L.; Donoghue, M. T. A.; Audenet, F.; Wong, N. C.; Pietzak, E. J.; Bielski, C. M.; Isharwal, S.; Iyer, G.; Funt, S.; Bagrodia, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy with etoposide plus cisplatin for patients with pathologic stage II nonseminomatous germ cell tumors
    Journal Article

    McHugh, D. J.; Funt, S. A.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J. S.; Patil, S.; Reuter, V. E.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Milowsky, M. I.; Appleman, L. J.; Dorff, T. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) arising from teratoma in late relapse germ cell tumor (GCT)
    Meeting Abstract

    Wong, N. C.; Dason, S.; Dean, L. W.; Isharwal, S.; Donoghue, M.; Jia, L.; Joseph, G.; Tap, W. D.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT)
    Meeting Abstract

    Dean, L. W.; Wong, N. C.; Dason, S.; Isharwal, S.; Donoghue, M.; Jia, L.; Tap, W. D.; Joseph, G.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Impact of teratoma on the cumulative incidence of disease-related death in patients with advanced germ cell tumors
    Journal Article

    Funt, S. A.; Patil, S.; Feldman, D. R.; Motzer, R. J.; Bajorin, D. F.; Sheinfeld, J.; Tickoo, S. K.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)
    Meeting Abstract

    Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter randomized phase 2 trial of paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Appleman, L. J.; Milowsky, M. I.; Patil, S.; Bromberg, M.; Nolan, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)
    Meeting Abstract

    McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save